Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons.

PubWeight™: 2.03‹?› | Rank: Top 2%

🔗 View Article (PMC 2516882)

Published in EMBO J on July 10, 2008

Authors

Emilie Colin1, Diana Zala, Géraldine Liot, Hélène Rangone, Maria Borrell-Pagès, Xiao-Jiang Li, Frédéric Saudou, Sandrine Humbert

Author Affiliations

1: Institut Curie, Orsay, France.

Articles citing this

(truncated to the top 100)

Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol (2009) 2.93

Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci (2012) 2.68

Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. J Cell Biol (2009) 2.45

Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet (2010) 2.36

Retrograde axonal transport: pathways to cell death? Trends Neurosci (2010) 2.06

Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci (2013) 2.05

JIP1 regulates the directionality of APP axonal transport by coordinating kinesin and dynein motors. J Cell Biol (2013) 2.01

Opposite-polarity motors activate one another to trigger cargo transport in live cells. J Cell Biol (2009) 2.00

Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci (2009) 1.95

Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol (2009) 1.88

Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J Clin Invest (2011) 1.79

Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci (2008) 1.59

Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron (2014) 1.55

Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta (2009) 1.52

Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum. Brain (2012) 1.49

Protein aggregates in Huntington's disease. Exp Neurol (2011) 1.46

Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol Biol Cell (2009) 1.45

Axonal transport and the delivery of pre-synaptic components. Curr Opin Neurobiol (2008) 1.38

CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog (2009) 1.35

Pericentrosomal targeting of Rab6 secretory vesicles by Bicaudal-D-related protein 1 (BICDR-1) regulates neuritogenesis. EMBO J (2010) 1.34

Bidirectional cargo transport: moving beyond tug of war. Nat Rev Mol Cell Biol (2014) 1.32

Integrated regulation of motor-driven organelle transport by scaffolding proteins. Trends Cell Biol (2014) 1.30

The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci (2014) 1.28

Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes. Mol Biol Cell (2010) 1.22

Hook is an adapter that coordinates kinesin-3 and dynein cargo attachment on early endosomes. J Cell Biol (2014) 1.21

Does Huntingtin play a role in selective macroautophagy? Cell Cycle (2010) 1.20

Targeting Huntington's disease through histone deacetylases. Clin Epigenetics (2011) 1.13

A Cdk5-dependent switch regulates Lis1/Ndel1/dynein-driven organelle transport in adult axons. J Neurosci (2011) 1.10

Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist (2011) 1.08

Cyclin-dependent kinase 5 regulates the polarized trafficking of neuropeptide-containing dense-core vesicles in Caenorhabditis elegans motor neurons. J Neurosci (2012) 1.05

The role of the cytoskeleton and molecular motors in endosomal dynamics. Semin Cell Dev Biol (2014) 1.04

A role for huntington disease protein in dendritic RNA granules. J Biol Chem (2010) 1.01

Ndel1 palmitoylation: a new mean to regulate cytoplasmic dynein activity. EMBO J (2009) 1.00

Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila. Mol Biol Cell (2012) 1.00

pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. Mol Brain (2010) 1.00

Desmosomal cadherins utilize distinct kinesins for assembly into desmosomes. J Cell Biol (2011) 0.98

Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev Mol Med (2010) 0.98

The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-κB from the synapse to the nucleus. Hum Mol Genet (2010) 0.97

Cellular therapy and induced neuronal replacement for Huntington's disease. Neurotherapeutics (2011) 0.97

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Mol Brain (2009) 0.96

Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases. Brain Res Rev (2008) 0.96

Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylation. Hum Mol Genet (2011) 0.96

The axonal cytoskeleton: from organization to function. Front Mol Neurosci (2015) 0.96

Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport. J Biol Chem (2012) 0.95

Huntingtin regulates mammary stem cell division and differentiation. Stem Cell Reports (2014) 0.95

New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases. World J Biol Chem (2014) 0.93

PGC-1α, mitochondrial dysfunction, and Huntington's disease. Free Radic Biol Med (2013) 0.92

Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. J Neuroinflammation (2013) 0.92

Huntingtin mediates dendritic transport of β-actin mRNA in rat neurons. Sci Rep (2011) 0.92

The dynein inhibitor Ciliobrevin D inhibits the bidirectional transport of organelles along sensory axons and impairs NGF-mediated regulation of growth cones and axon branches. Dev Neurobiol (2014) 0.92

Impaired mitochondrial trafficking in Huntington's disease. Biochim Biophys Acta (2009) 0.91

The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Curr Trends Neurol (2011) 0.90

Perturbation of the Akt/Gsk3-β signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs. Hum Mol Genet (2011) 0.90

Subpixel colocalization reveals amyloid precursor protein-dependent kinesin-1 and dynein association with axonal vesicles. Proc Natl Acad Sci U S A (2012) 0.90

Role of kinesin light chain-2 of kinesin-1 in the traffic of Na,K-ATPase-containing vesicles in alveolar epithelial cells. FASEB J (2009) 0.88

Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders. Toxicol Sci (2012) 0.88

Localization of BDNF mRNA with the Huntington's disease protein in rat brain. Mol Neurodegener (2010) 0.87

Axonal transport and neurodegenerative disease: can we see the elephant? Prog Neurobiol (2012) 0.87

Huntington's Disease and Striatal Signaling. Front Neuroanat (2011) 0.86

DISC1 regulates synaptic vesicle transport via a lithium-sensitive pathway. Neurosci Res (2011) 0.86

Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci (2014) 0.86

Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art. Neuropathol Appl Neurobiol (2015) 0.85

Huntington's disease: the past, present, and future search for disease modifiers. Yale J Biol Med (2013) 0.85

Huntingtin's function in axonal transport is conserved in Drosophila melanogaster. PLoS One (2013) 0.85

A Genome-wide RNAi Screen for Microtubule Bundle Formation and Lysosome Motility Regulation in Drosophila S2 Cells. Cell Rep (2016) 0.84

TRIM3 regulates the motility of the kinesin motor protein KIF21B. PLoS One (2013) 0.84

A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice. Nat Commun (2013) 0.83

The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors. Membranes (Basel) (2014) 0.83

Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener (2014) 0.83

Ndel1-derived peptides modulate bidirectional transport of injected beads in the squid giant axon. Biol Open (2012) 0.83

PATHOLOGIES OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASES. Transl Neurosci (2012) 0.81

Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. PLoS One (2014) 0.81

Huntingtin Is Required for Epithelial Polarity through RAB11A-Mediated Apical Trafficking of PAR3-aPKC. PLoS Biol (2015) 0.81

Scalable production in human cells and biochemical characterization of full-length normal and mutant huntingtin. PLoS One (2015) 0.80

Axon diameter and axonal transport: In vivo and in vitro effects of androgens. Neuroimage (2015) 0.80

Prospects for neuroprotective therapies in prodromal Huntington's disease. Mov Disord (2014) 0.80

BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J Neurochem (2014) 0.79

A huntingtin-mediated fast stress response halting endosomal trafficking is defective in Huntington's disease. Hum Mol Genet (2014) 0.79

At the Fulcrum in Health and Disease: Cdk5 and the Balancing Acts of Neuronal Structure and Physiology. Brain Disord Ther (2012) 0.79

Mechanisms and functions of lysosome positioning. J Cell Sci (2016) 0.78

Signaling Over Distances. Mol Cell Proteomics (2015) 0.78

Deceivingly dynamic: Learning-dependent changes in stathmin and microtubules. Neurobiol Learn Mem (2015) 0.78

AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease. Gene Ther (2015) 0.78

Huntingtin differentially regulates the axonal transport of a sub-set of Rab-containing vesicles in vivo. Hum Mol Genet (2015) 0.78

Specific sets of intrinsic and extrinsic factors drive excitatory and inhibitory circuit formation. Neuroscientist (2011) 0.78

Amyloid-Beta Induced Changes in Vesicular Transport of BDNF in Hippocampal Neurons. Neural Plast (2016) 0.77

Retrograde NGF axonal transport--motor coordination in the unidirectional motility regime. Biophys J (2015) 0.77

Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein. J Biol Chem (2014) 0.76

Serine 421 regulates mutant huntingtin toxicity and clearance in mice. J Clin Invest (2016) 0.76

Altered lysosomal positioning affects lysosomal functions in a cellular model of Huntington's disease. Eur J Neurosci (2015) 0.76

Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics. Mar Drugs (2016) 0.75

Polyglutamine Tract Expansion Increases S-Nitrosylation of Huntingtin and Ataxin-1. PLoS One (2016) 0.75

Spatial and temporal characteristics of normal and perturbed vesicle transport. PLoS One (2014) 0.75

Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease. Mol Ther (2015) 0.75

The Roles of Microtubule-Based Transport at Presynaptic Nerve Terminals. Front Synaptic Neurosci (2016) 0.75

Is Huntingtin Dispensable in the Adult Brain? J Huntingtons Dis (2017) 0.75

Glucocorticoid affects dendritic transport of BDNF-containing vesicles. Sci Rep (2015) 0.75

Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies. Int J Mol Sci (2017) 0.75

Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing. Mol Ther Methods Clin Dev (2017) 0.75

Post-translational modifications (PTMs), identified on endogenous huntingtin, cluster within proteolytic domains between HEAT repeats. J Proteome Res (2017) 0.75

Articles cited by this

The molecular motor toolbox for intracellular transport. Cell (2003) 9.97

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell (1998) 7.13

Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J Cell Biol (1997) 6.57

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell (2004) 5.67

Kinesin and dynein move a peroxisome in vivo: a tug-of-war or coordinated movement? Science (2005) 5.58

Dynactin. Annu Rev Cell Dev Biol (2004) 5.46

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science (2001) 5.28

The axonal transport of mitochondria. J Cell Sci (2005) 5.19

Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein). J Neurosci (2003) 4.72

Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol (2006) 4.28

Bidirectional transport along microtubules. Curr Biol (2004) 4.21

Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron (2003) 4.04

Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature (1997) 4.01

Developmental regulation of vesicle transport in Drosophila embryos: forces and kinetics. Cell (1998) 3.84

Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci (2007) 3.79

Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. Mol Biol Cell (1999) 3.28

Dynactin is required for bidirectional organelle transport. J Cell Biol (2003) 3.04

A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc Natl Acad Sci U S A (1990) 2.89

Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons. Mol Biol Cell (2000) 2.73

A huntingtin-associated protein enriched in brain with implications for pathology. Nature (1995) 2.67

The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell (2002) 2.56

KIF5C, a novel neuronal kinesin enriched in motor neurons. J Neurosci (2000) 2.43

A mutant of the motor protein kinesin that moves in both directions on microtubules. Nature (2000) 2.42

Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum Mol Genet (1997) 2.28

The role of kinesin and other soluble factors in organelle movement along microtubules. J Cell Biol (1988) 2.27

The interaction between cytoplasmic dynein and dynactin is required for fast axonal transport. Proc Natl Acad Sci U S A (1997) 2.26

Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A (2007) 2.16

Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci (2004) 2.16

Interaction of huntingtin-associated protein with dynactin P150Glued. J Neurosci (1998) 1.98

Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem (2005) 1.98

A direct interaction between cytoplasmic dynein and kinesin I may coordinate motor activity. J Biol Chem (2004) 1.97

Changes in microtubule polarity orientation during the development of hippocampal neurons in culture. J Cell Biol (1989) 1.94

Role of tetanus neurotoxin insensitive vesicle-associated membrane protein (TI-VAMP) in vesicular transport mediating neurite outgrowth. J Cell Biol (2000) 1.82

The role of the dynactin complex in intracellular motility. Int Rev Cytol (1998) 1.75

Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci (2006) 1.57

Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J Cell Biol (2006) 1.55

The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J (2007) 1.55

A determinant for directionality of organelle transport in Drosophila embryos. Curr Biol (2003) 1.51

Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A (1995) 1.50

Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport (1997) 1.20

Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci (2006) 1.16

Neurotrophins: a ticket to ride for BDNF. Curr Biol (2005) 0.95

Articles by these authors

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell (2004) 5.67

Towards a transgenic model of Huntington's disease in a non-human primate. Nature (2008) 4.47

Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J (2006) 4.43

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet (2003) 4.07

Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci (2007) 3.79

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci (2008) 3.54

Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet (2004) 2.88

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol (2005) 2.57

The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell (2002) 2.56

Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron (2010) 2.54

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A (2003) 2.35

Vesicular glycolysis provides on-board energy for fast axonal transport. Cell (2013) 2.33

Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol (2011) 2.24

Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci (2003) 2.20

Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol (2002) 2.19

N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci (2008) 2.18

Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron (2005) 2.11

Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem (2005) 1.98

Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A (2009) 1.87

Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nat Med (2006) 1.86

Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J Clin Invest (2011) 1.79

Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. J Cell Biol (2003) 1.77

Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Hum Mol Genet (2008) 1.70

Transgenic rat model of Huntington's disease. Hum Mol Genet (2003) 1.66

Polyglutamine expansion of huntingtin impairs its nuclear export. Nat Genet (2005) 1.62

Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci (2009) 1.56

Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin. Neuron (2010) 1.54

Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J Cell Biol (2008) 1.51

Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell (2006) 1.51

Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J Neurosci (2002) 1.48

Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration. Nat Neurosci (2007) 1.46

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest (2006) 1.44

Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons. J Neurosci (2008) 1.41

Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci (2002) 1.40

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr Opin Neurol (2008) 1.40

Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease. Hum Mol Genet (2005) 1.39

Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease. Mol Neurodegener (2007) 1.39

Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener (2006) 1.35

Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J Neurosci (2003) 1.35

Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet (2010) 1.33

Characterization of a brain-enriched chaperone, MRJ, that inhibits Huntingtin aggregation and toxicity independently. J Biol Chem (2002) 1.29

Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet (2008) 1.28

Akt is altered in an animal model of Huntington's disease and in patients. Eur J Neurosci (2005) 1.27

Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem (2010) 1.25

Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J Neurosci (2006) 1.23

Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J Neurosci (2008) 1.23

Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet (2008) 1.23

Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. J Cell Biol (2008) 1.22

Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci U S A (2006) 1.20

Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J Neurosci (2007) 1.20

Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease. EMBO J (2010) 1.19

Huntingtin-associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice. J Clin Invest (2008) 1.19

Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem (2003) 1.17

Huntingtin and its role in neuronal degeneration. Neuroscientist (2004) 1.16

Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J Neurosci (2006) 1.16

The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci (2004) 1.15

Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet (2002) 1.14

Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J (2011) 1.12

Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet (2003) 1.11

TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J Cereb Blood Flow Metab (2006) 1.10

Elongator - an emerging role in neurological disorders. Trends Mol Med (2009) 1.10

Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Hum Mol Genet (2010) 1.08

Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. Proc Natl Acad Sci U S A (2003) 1.05

Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. FASEB J (2007) 1.05

Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem (2011) 1.05

Klp10A, a microtubule-depolymerizing kinesin-13, cooperates with CP110 to control Drosophila centriole length. Curr Biol (2012) 1.03

Tissue plasminogen activator prevents white matter damage following stroke. J Exp Med (2011) 1.03

Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. Brain (2011) 1.03

The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Mol Cell Neurosci (2005) 1.00

pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. Mol Brain (2010) 1.00

Regulation of intracellular HAP1 trafficking. J Neurosci Res (2007) 0.99

Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity. J Biol Chem (2008) 0.98

Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neurosci Lett (2011) 0.97

Phosphorylation of arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced toxicity by rescuing proteasome impairment. J Biol Chem (2005) 0.97

Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem (2009) 0.96

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Mol Brain (2009) 0.96

Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci (2013) 0.96